Blind Adaptive Local Denoising for CEST Imaging

Chu Chen, Aitor Artola, Yang Liu, Se Weon Park, Raymond H. Chan, Jean-Michel Morel, Kannie W. Y. ChanarXiv 2025 · DOI · arXiv

Abstract: Chemical Exchange Saturation Transfer (CEST) MRI is a powerful molecular imaging technique, but its clinical utility is often hampered by low signal-to-noise ratios and signal-dependent, heteroscedastic noise. This paper presents Blind Adaptive Local Denoising (BALD), an unsupervised framework that estimates noise characteristics directly from raw data. By combining an Adaptive Variance Stabilization Transform (AVST) with a two-stage local Singular Value Decomposition (SVD) denoising process, BALD effectively transforms complex noise into a uniform Gaussian distribution, enabling high-fidelity signal recovery. Experimental results on synthetic, physical, and in vivo datasets demonstrate that BALD outperforms state-of-the-art methods in both signal preservation and computational efficiency.

Introduction

CEST MRI enables the visualization of low-concentration metabolites by monitoring proton exchange with water. However, the resulting signals are weak and highly susceptible to heteroscedastic noise, which varies with signal intensity and hardware. Traditional denoising methods often fail because they assume uniform "white" noise, leading to either residual artifacts in dark regions or over-smoothing of critical spectral features. Furthermore, supervised deep learning approaches often lack generalizability across different scanners. BALD addresses these challenges by providing a "blind" denoising solution that requires no prior knowledge of noise characteristics or training data.

Methodology

The BALD framework follows a "stabilize-denoise-restore" pipeline, as illustrated in the workflow below.

Overview of the BALD framework, illustrating the AVST process, local SVD denoising stages, and final restoration.
  1. Adaptive Variance Stabilization Transform (AVST): The algorithm estimates the noise model by analyzing the smoothness of the z-spectrum using second-order finite differences. It then applies a mathematical transform to homogenize noise variance across the entire image sequence.
  2. Two-Stage Local SVD Denoising:
    • Stage 1 (Hard Thresholding): The stabilized image is processed in small patches using SVD to separate signal from noise. A hard threshold is applied to create an initial "oracle" denoised version.
  3. Stage 2 (Wiener Filtering): The oracle guides a second SVD pass with optimal shrinkage factors to refine the denoising while preserving edges and fine details.
  4. Inverse AVST (iAVST): Finally, the data is transformed back to its original intensity domain, ensuring compatibility with standard clinical analysis.

Experimental Evaluation

The performance of BALD was validated across three distinct datasets:

  • Synthetic Phantoms: Simulated using Bloch-McConnell equations to provide ground truth for Amide Proton Transfer (APT) and Nuclear Overhauser Effect (NOE) signals.
  • Physical Phantoms: Dopamine Hydrochloride samples at various concentrations, scanned multiple times to establish a reference for noisy vs. averaged data.
  • In Vivo Data: Mouse brain models with U-87 MG tumors, evaluating the framework's ability to distinguish pathological features in complex biological environments.

Results and Discussion

BALD demonstrated superior performance across all metrics. In synthetic tests, it consistently surpassed baselines like BM4D and DECENT by at least 1 dB in Peak Signal-to-Noise Ratio (PSNR). On real dopamine phantoms, BALD achieved a 3 dB PSNR gain over raw data.

A significant insight is that the AVST step acts as a "universal adapter," allowing denoising models trained on natural images to be effectively applied to medical CEST data. By exploiting the inherent spectral smoothness of tissue, BALD avoids the "spectral leakage" common in global denoising methods. In clinical mouse tumor models, BALD provided the sharpest contrast and most statistically significant tumor detection (via T-tests), preserving the diagnostic integrity of the scans. Additionally, with a processing time of approximately 35 seconds per sequence, BALD is highly efficient for real-time applications.

Conclusion

BALD offers a robust, unsupervised solution for CEST MRI denoising. While its performance depends on the accuracy of initial noise estimation—which may be affected by extreme motion—it provides a significant advancement in molecular imaging. Future work will explore integrating BALD as a pre-processing module for hybrid deep learning pipelines, combining classical physics-based reliability with modern AI capabilities.

Summary updated

Abstract

Chemical Exchange Saturation Transfer (CEST) MRI enables molecular-level visualization of low-concentration metabolites by leveraging proton exchange dynamics. However, its clinical translation is hindered by inherent challenges: spatially varying noise arising from hardware limitations, and complex imaging protocols introduce heteroscedasticity in CEST data, perturbing the accuracy of quantitative contrast mapping such as amide proton transfer (APT) imaging. Traditional denoising methods are not designed for this complex noise and often alter the underlying information that is critical for biomedical analysis. To overcome these limitations, we propose a new Blind Adaptive Local Denoising (BALD) method. BALD exploits the self-similar nature of CEST data to derive an adaptive variance-stabilizing transform that equalizes the noise distributions across CEST pixels without prior knowledge of noise characteristics. Then, BALD performs two-stage denoising on a linear transformation of data to disentangle molecular signals from noise. A local SVD decomposition is used as a linear transform to prevent spatial and spectral denoising artifacts. We conducted extensive validation experiments on multiple phantoms and \textit{in vivo} CEST scans. In these experiments, BALD consistently outperformed state-of-the-art CEST denoisers in both denoising metrics and downstream tasks such as molecular concentration maps estimation and cancer detection.
BibTeX
@misc{chen2025blind,
  author = {Chu Chen and Aitor Artola and Yang Liu and Se Weon Park and Raymond H. Chan and Jean-Michel Morel and Kannie W. Y. Chan},
  title = {{Blind Adaptive Local Denoising for CEST Imaging}},
  year = {2025},
  eprint = {2511.20081},
  archivePrefix = {arXiv},
  url = {https://arxiv.org/abs/2511.20081},
}
Figure